|
US2012122966A1
|
|
Use of organic dyes as analgesic agents
|
|
RU2385153C1
|
|
Application of liquid crystals as medical products
|
|
RU2361587C1
|
|
Medical product for treatment of oncologic diseases
|
|
RU2360686C1
|
|
Medicinal agent for oncotherapy
|
|
RU2354384C1
|
|
Application of organic dyes as means for treatment of oncological diseases
|
|
RU2381027C2
|
|
Application of fungicide as agent for treating oncologic diseases
|
|
RU2349311C1
|
|
Application of naphthalene derivative as oncological disease treatment medicine
|
|
RU2378989C2
|
|
Method of diagnostics by means of ultrasonic, sonic and electromagnetic waves
|
|
RU2354369C2
|
|
Application of rhodamine 6g as medication for treatment of malignant neoplasms and amyloidoses
|
|
RU2322973C1
|
|
Use of malachite green as drug in treatment of malignant neoplasm
|
|
RU2343929C2
|
|
Method of obtaining of biologically active preparation (versions) and biologically active preparation
|
|
WO2008054238A1
|
|
Biologically active preparation (variants) and a method for the production thereof (variants)
|
|
RU2370269C2
|
|
Method of malignant tumor treatment and gas composition (versions) for its realisation
|
|
RU2308270C1
|
|
Pharmaceutical agent
|
|
US2009221708A1
|
|
Medicinal preparation
|
|
US2007071977A1
|
|
Magnetically operated absorbent and method for the production thereof
|
|
EA009095B1
|
|
Magnetically operated absorbent and method for the production thereof
|
|
EP1685863A1
|
|
System for correcting biological fluid
|
|
EP1747777A1
|
|
Medicinal agent
|
|
RU2295335C2
|
|
Drugs having immunomodulatory, anti-inflammatory and anti-tumor properties and method for production thereof
|
